TACC1 Activators are a collection of chemical compounds that influence cellular signaling and microtubule dynamics to indirectly enhance the function of TACC1. Forskolin, by increasing cAMP levels, activates PKA, which can phosphorylate various proteins, potentially including those that interact with TACC1 to stabilize microtubules. Similarly, PMA's activation of PKC and lithium chloride's inhibition of GSK-3β may modify the phosphorylation state of proteins associated with microtubule regulation, indirectly increasing TACC1's ability to stabilize these cellular structures. Paclitaxel, a microtubule stabilizer, and Vinblastine, a microtubule assembly inhibitor, exert their effects on microtubule dynamics, which can synergize with TACC1's inherent stabilizing function. Nocodazole's disruption of microtubules and S-Trityl-L-cysteine's inhibition of Eg5 may lead to cellular compensatory mechanisms that upregulate TACC1's activity in microtubule stabilization during mitotic spindle assembly.
TACC1 Activators exert their influence by interacting with TACC1 and influencing its function. Microtubules are essential structural components within cells, serving as tracks for intracellular transport and playing a pivotal role in processes such as mitosis and cell motility. TACC1 has been identified as a microtubule-associated protein that is capable of stabilizing and organizing microtubules during these critical cellular functions. TACC1 Activators likely work by enhancing or modulating TACC1's interaction with microtubules, leading to alterations in microtubule dynamics. This, in turn, can have far-reaching effects on cellular processes, influencing the structure and behavior of cells. While the specific mechanisms and structures of TACC1 Activators can vary widely, their commonality lies in their ability to target TACC1 and influence its role in the intricate dance of microtubule regulation within cells.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, increasing cAMP levels, which can lead to activation of PKA. PKA phosphorylation of target proteins could enhance the microtubule-stabilizing function of TACC1. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which may phosphorylate substrates involved in microtubule dynamics, potentially enhancing TACC1's role in microtubule stabilization. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride inhibits GSK-3β, which may lead to reduced phosphorylation of microtubule-associated proteins and could indirectly enhance TACC1's microtubule stabilization activity. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine inhibits DNA methyltransferases, potentially leading to the hypomethylation of the TACC1 gene, which can upregulate TACC1 protein expression and activity. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is a potent inhibitor of serine/threonine phosphatases, which may enhance the phosphorylation status of TACC1 or its interacting proteins, indirectly increasing TACC1 activity. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a kinase inhibitor that may reduce the activity of kinases which negatively regulate TACC1, potentially leading to enhanced TACC1 function in microtubule stabilization. | ||||||
S-Trityl-L-cysteine | 2799-07-7 | sc-202799 sc-202799A | 1 g 5 g | $32.00 $66.00 | 6 | |
S-Trityl-L-cysteine is a specific inhibitor of Eg5, a kinesin motor protein. Inhibition of Eg5 can lead to mitotic arrest, where TACC1's role in centrosome-microtubule interactions may be enhanced. | ||||||
Dimethyloxaloylglycine (DMOG) | 89464-63-1 | sc-200755 sc-200755A sc-200755B sc-200755C | 10 mg 50 mg 100 mg 500 mg | $84.00 $301.00 $374.00 $779.00 | 25 | |
DMOG inhibits prolyl hydroxylases, leading to the stabilization of HIF-1α. HIF-1α can induce genes involved in the response to hypoxia, which might include TACC1 or its pathway components. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG132 is a proteasome inhibitor that can prevent the degradation of proteins involved in the regulation of microtubule dynamics, possibly leading to an enhanced effect of TACC1 on microtubule stability. | ||||||